OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro study
Hao Wu, Lin Yang, Hanjie Liu, et al.
CNS Neuroscience & Therapeutics (2021) Vol. 27, Iss. 12, pp. 1587-1604
Open Access | Times Cited: 31
Hao Wu, Lin Yang, Hanjie Liu, et al.
CNS Neuroscience & Therapeutics (2021) Vol. 27, Iss. 12, pp. 1587-1604
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Dual‐Targeted Novel Temozolomide Nanocapsules Encapsulating siPKM2 Inhibit Aerobic Glycolysis to Sensitize Glioblastoma to Chemotherapy
Yongkang Zhang, Hongwei Ma, Lin-Sen Li, et al.
Advanced Materials (2024) Vol. 36, Iss. 29
Closed Access | Times Cited: 9
Yongkang Zhang, Hongwei Ma, Lin-Sen Li, et al.
Advanced Materials (2024) Vol. 36, Iss. 29
Closed Access | Times Cited: 9
The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy
Guilong Tanzhu, Liu Chen, Gang Xiao, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 30
Guilong Tanzhu, Liu Chen, Gang Xiao, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 30
Hypoxia‐induced polypoid giant cancer cells in glioma promote the transformation of tumor‐associated macrophages to a tumor‐supportive phenotype
Yuyang Liu, Ying Shi, Mengwan Wu, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 9, pp. 1326-1338
Open Access | Times Cited: 26
Yuyang Liu, Ying Shi, Mengwan Wu, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 9, pp. 1326-1338
Open Access | Times Cited: 26
Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment
Bo Chen, Xiaoxi Zhou, Liting Yang, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 12, pp. 2148-2162
Open Access | Times Cited: 23
Bo Chen, Xiaoxi Zhou, Liting Yang, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 12, pp. 2148-2162
Open Access | Times Cited: 23
SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes
Liang Zeng, Zheng Wang, Xinglong Liu, et al.
Theranostics (2023) Vol. 13, Iss. 11, pp. 3725-3743
Open Access | Times Cited: 16
Liang Zeng, Zheng Wang, Xinglong Liu, et al.
Theranostics (2023) Vol. 13, Iss. 11, pp. 3725-3743
Open Access | Times Cited: 16
circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling
Shengchao Xu, Chengke Luo, Dikang Chen, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 15
Shengchao Xu, Chengke Luo, Dikang Chen, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 15
FBXO22 promotes glioblastoma malignant progression by mediating VHL ubiquitination and degradation
Zhigang Shen, Tao Dong, Hongmei Yong, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Zhigang Shen, Tao Dong, Hongmei Yong, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Glioblastoma Tumor Microenvironment: An Important Modulator for Tumoral Progression and Therapy Resistance
Ligia Gabriela Tătăranu, Șerban Turliuc, A. El Kamel, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 9881-9894
Open Access | Times Cited: 4
Ligia Gabriela Tătăranu, Șerban Turliuc, A. El Kamel, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 9881-9894
Open Access | Times Cited: 4
Advanced Disease Therapeutics Using Engineered Living Drug Delivery Systems
Narsimha Mamidi, Fátima Franco De Silva, Amin Orash Mahmoud Salehi
Nanoscale (2025)
Closed Access
Narsimha Mamidi, Fátima Franco De Silva, Amin Orash Mahmoud Salehi
Nanoscale (2025)
Closed Access
A novel real-time efficacy assessment method for tumor treating fields
Yueyue Xiao, Songpei Hu, Chunxiao Chen, et al.
Engineering Analysis with Boundary Elements (2025) Vol. 177, pp. 106278-106278
Closed Access
Yueyue Xiao, Songpei Hu, Chunxiao Chen, et al.
Engineering Analysis with Boundary Elements (2025) Vol. 177, pp. 106278-106278
Closed Access
Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields])
Shadi Shams, Chirag B. Patel
Journal of Molecular Cell Biology (2022) Vol. 14, Iss. 8
Open Access | Times Cited: 16
Shadi Shams, Chirag B. Patel
Journal of Molecular Cell Biology (2022) Vol. 14, Iss. 8
Open Access | Times Cited: 16
Therapeutic potential of tumor treating fields for malignant brain tumors
Youyou Zhou, Xiaoqing Xing, Jinyun Zhou, et al.
Cancer Reports (2023) Vol. 6, Iss. 5
Open Access | Times Cited: 10
Youyou Zhou, Xiaoqing Xing, Jinyun Zhou, et al.
Cancer Reports (2023) Vol. 6, Iss. 5
Open Access | Times Cited: 10
Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma
Shengchao Xu, Chengke Luo, Dikang Chen, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 15
Shengchao Xu, Chengke Luo, Dikang Chen, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 15
Tumor treating fields: a comprehensive overview of the underlying molecular mechanism
Pengjie Hong, Nijiati Kudulaiti, Shuai Wu, et al.
Expert Review of Molecular Diagnostics (2021) Vol. 22, Iss. 1, pp. 19-28
Closed Access | Times Cited: 19
Pengjie Hong, Nijiati Kudulaiti, Shuai Wu, et al.
Expert Review of Molecular Diagnostics (2021) Vol. 22, Iss. 1, pp. 19-28
Closed Access | Times Cited: 19
Advanced tumor electric fields therapy: A review of innovative research and development and prospect of application in glioblastoma
Jinxin Lan, Yuyang Liu, Junyi Chen, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 2
Jinxin Lan, Yuyang Liu, Junyi Chen, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 2
Identification and validation of COL6A1 as a novel target for tumor electric field therapy in glioblastoma
J L Chen, Yuyang Liu, Jinxin Lan, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 6
Open Access | Times Cited: 2
J L Chen, Yuyang Liu, Jinxin Lan, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 6
Open Access | Times Cited: 2
Insights about circadian clock in glioma: From molecular pathways to therapeutic drugs
Zongqi Wang, Gang Chen
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 12, pp. 1930-1941
Open Access | Times Cited: 8
Zongqi Wang, Gang Chen
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 12, pp. 1930-1941
Open Access | Times Cited: 8
Tumor-treating fields in cancer therapy: advances of cellular and molecular mechanisms
Tong Xiao, Hao Zheng, Kaiyang Zu, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
Tong Xiao, Hao Zheng, Kaiyang Zu, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
Minimally-invasive implantable device enhances brain cancer suppression
Xiaona Cao, Jie Li, Jinliang Ren, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 7, pp. 1704-1716
Open Access | Times Cited: 1
Xiaona Cao, Jie Li, Jinliang Ren, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 7, pp. 1704-1716
Open Access | Times Cited: 1
Identification of CD101 in Glioma: A Novel Prognostic Indicator Expressed on M2 Macrophages
Yuyang Liu, Ren-qi Yao, Ying Shi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Yuyang Liu, Ren-qi Yao, Ying Shi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Ion channels as molecular targets of glioblastoma electrotherapy
Tayeb Abed, Katrin Ganser, Franziska Eckert, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 3
Tayeb Abed, Katrin Ganser, Franziska Eckert, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 3
Design and Modeling of a Device Combining Single-Cell Exposure to a Uniform Electrical Field and Simultaneous Characterization via Bioimpedance Spectroscopy
Rémi Bettenfeld, Julien Claudel, Djilali Kourtiche, et al.
Sensors (2023) Vol. 23, Iss. 7, pp. 3460-3460
Open Access | Times Cited: 2
Rémi Bettenfeld, Julien Claudel, Djilali Kourtiche, et al.
Sensors (2023) Vol. 23, Iss. 7, pp. 3460-3460
Open Access | Times Cited: 2
FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis
Zhimin Sun, Xiaoli Sun, Yaqin Yuan, et al.
Medicine (2023) Vol. 102, Iss. 37, pp. e35084-e35084
Open Access | Times Cited: 2
Zhimin Sun, Xiaoli Sun, Yaqin Yuan, et al.
Medicine (2023) Vol. 102, Iss. 37, pp. e35084-e35084
Open Access | Times Cited: 2
